Sajad Khazal, MB. ChB.
Department of Pediatrics, Division of Pediatrics
Education & Training
|2012-2015||Clinical Fellowship, Pediatric Hematology and Oncology, Children’s Hospital Los Angeles, Los Angeles, CA|
|2009-2011||Clinical Residency, General Pediatrics - Chief Resident, The Brooklyn Hospital Center, Brooklyn, NY|
|2008-2009||Clinical Internship, General Pediatrics, The Brooklyn Hospital Center, Brooklyn, NY|
|2004-2006||Clinical Residency, Department of Urology, College of Medicine/University of Baghdad/Medical City/Surgical Subspecialties Hospital, Baghdad|
|2002-2004||Clinical Internship, Al-Yarmouk Teaching Hospital, Baghdad|
|2011||The American Board of Pediatrics|
Experience & Service
Assistant Professor, Department of Pediatrics Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2022
Assistant Professor, Department of Pediatric Marrow and Blood Cell Transplantation Program, Division of Pediatrics, Albert Einstein College of Medicine of Yeshiva University Children’s Hospital at Montefiore, Bronx, NY, 2015 - 2017
- Li L, Qi X, Sun W, Abdel-Azim H, Lou S, Zhu H, Prasadarao NV, Zhou A, Shimada H, Shudo K, Kim YM, Khazal S, He Q, Warburton D, Wu L. Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortality. EMBO Mol Med 8(11):1340-1359, 2016. e-Pub 2016. PMID: 27737899.
Letters to the Editor
- Khazal S, Polishchuk V, Manwani D, Gallagher PG, Prinzing S, Mahadeo KM. Allogeneic bone marrow transplantation for treatment of severe hemolytic anemia attributable to hexokinase deficiency. Blood 128: 735-7, 2016.
- Khazal S, Abdel-Azim H, Kapoor N, Mahadeo KM. Overcoming psychosocial and developmental barriers to blood and marrow transplantation (BMT) in an adolescent/young adult (AYA) transgender patient with chronic myelogenous leukemia. Pediatric Hematology and Oncology 31: 765-767, 2014.
- Hsieh YT, Gang EJ, Shishido SN, Kim HN, Pham J, Khazal S, Osborne A, Esguerra ZA, Kwok E, Jang J, Bonig H, Biediger RJ, Vanderslice P, Kim YM. Effects of the small-molecule inhibitor of integrin α4, TBC3486, on pre-B-ALL cells. Leukemia 28: 2101-2104, 2014.